Black Hawk Acquisition Corp. Files 8-K

Ticker: BKHAR · Form: 8-K · Filed: Jun 20, 2025 · CIK: 2000775

Black Hawk Acquisition CORP 8-K Filing Summary
FieldDetail
CompanyBlack Hawk Acquisition CORP (BKHAR)
Form Type8-K
Filed DateJun 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, biological-products

Related Tickers: BKHAU

TL;DR

BHAC filed an 8-K, confirming its focus on biological products (non-diagnostic).

AI Summary

On June 20, 2025, Black Hawk Acquisition Corp. filed an 8-K report. The filing indicates that the company is involved in the biological products sector, specifically excluding diagnostic substances. The company's principal executive offices are located at 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.

Why It Matters

This filing provides an update on Black Hawk Acquisition Corp.'s corporate status and business sector, which is relevant for investors tracking the company's activities.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report detailing corporate information and does not appear to contain significant new financial or operational risks.

Key Players & Entities

FAQ

What is the primary business of Black Hawk Acquisition Corp.?

Black Hawk Acquisition Corp. is involved in Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code.

When was this 8-K report filed?

This 8-K report was filed on June 20, 2025.

Where are Black Hawk Acquisition Corp.'s principal executive offices located?

The principal executive offices are located at 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.

What is the company's fiscal year end?

The company's fiscal year end is November 30 (1130).

What is the Commission File Number for Black Hawk Acquisition Corp.?

The Commission File Number is 001-41984.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Black Hawk Acquisition Corp (BKHAR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing